Related by context. All words. (Click for frequent words.) 70 triggers apoptosis programmed 70 accumulate preferentially 68 selectively inhibit replication 68 histone deacetylase HDAC 67 HepDirect R 67 ribonucleotide reductase clinically validated 67 pipeline GlycoPEG GCSF 67 adhesion molecule EpCAM expressing 66 polysaccharide polymer 66 identify protein biomarkers 66 antiangiogenesis therapies 66 insomnia migraine headaches 66 HuCNS SC ® 66 5 HT2A serotonin 65 specific lectin receptors 65 angina nausea 65 demonstrated anti amnesic 65 Idera Pharmaceuticals develops 65 targets Galectin receptors 65 semi synthetic lipoglycopeptide 65 RAS MAPK pathway 65 infectious diseases autoimmune diseases 65 anionic backbone 65 MCSP respectively 65 IAP inhibitor 65 modulate ion channel 65 regulate therapeutically important 65 anti gastrin monoclonal 64 attach auristatin 64 TRIOLEX HE# APOPTONE HE# 64 diagnostic biomarkers 64 ASONEP ™ 64 neurodegenerative diseases Alzheimer disease 64 Panzem NCD 64 sulfonylhydrazine class 64 GRNOPC1 contains 64 kidney urologic 64 indications Cytokinetics 64 humanized therapeutic 64 targeting abnormally proliferating 64 CEA CD# Her2 64 M2 subunit 64 THR beta agonist 64 stranded LNA 63 activate SIRT1 63 commercializing oxidized glutathione 63 kinase PI3K 63 protein receptors lectins 63 NuMimetic TM 63 Factor Receptor 63 Alfacell proprietary ribonuclease 63 commercialize CorMedix drug 63 TOCOSOL Camptothecin 63 VEGFR2 inhibitor 63 preferentially bind 63 using VIAdel TM 63 ASONEP TM 63 infectious diseases autoimmune 63 Smac mimetic 63 selectively inhibited 63 MAbs targeting 63 CD# expressing 63 secretory phospholipase A2 63 potently inhibit 63 MSCRAMM ® 62 antisense therapies 62 Sphingomab 62 IMPDH inhibitor 62 AAG geldanamycin analog 62 injectable investigational 62 psoriasis rheumatoid arthritis 62 novel antimitotic agent 62 ErbB3 HER3 62 transthyretin TTR 62 oral Janus kinase 62 Smac mimetics 62 PI3K/mTOR 62 novel orally administered 62 targeted diseased tissues 62 multi kinase inhibitor 62 alpha folate receptor 62 M# rationally 62 included Raf kinase 62 non porcine pancreatic 62 XL# anticancer compounds 62 MediGene focuses 61 SIX RO ROG 61 humanized monoclonal antibodies 61 PI3K AKT 61 colorectal bladder 61 protein tyrosine phosphatase 1B 61 CYT# potent vascular disrupting 61 therapeutic monoclonal antibody 61 reformulates existing FDA 61 targeted radiotherapeutic 61 CYT# vascular disrupting 61 CCR9 antagonist 61 taxane derivative 61 inhibit angiogenesis 61 anti miRs antisense oligonucleotide 61 EGFR pathway 61 telomerase inhibitor 61 peptidic compound 61 anti botulism antibody 61 novel tubulin binding 61 Darapladib 61 Tumour VDA 61 lung pancreatic 61 fungal infections malaria tuberculosis 61 PNP inhibitor 61 active cellular immunotherapy 61 Apoptone HE# 61 AVI antisense 61 DG# compounds targeting 61 bioactive carbohydrates 61 Provectus Pharmaceuticals specializes 61 hypercholesterolemia liver 61 novel L DOS# 61 cytolytic 61 Pruvel TM 61 Angiocept 61 CDK cyclin dependent 61 gastro intestinal inflammation 61 candidates Azedra TM 61 hypoxia selective 61 Protein Kinase C 60 apoptosis proteins 60 Cathepsin B 60 carbohydrate polymer 60 BRAF inhibitors 60 treats acute lymphoblastic 60 pancreatic islet beta 60 including HGF ErbB3 60 orally administered inhibitor 60 ALTROPANE R 60 basal cell carcinoma squamous 60 protein synthesis machinery 60 antibacterial antifungal 60 selectively inhibit 60 colon carcinomas 60 RON Notch 60 Solazed TM 60 fusion enhancers 60 antimitotic 60 neuronal nicotinic receptors NNRs 60 human airway epithelial 60 messenger RNAs mRNAs thereby 60 Locked Nucleic Acid LNA 60 PLX MS 60 TRIOLEX HE# 60 Delta opioid receptor 60 alpha glucans 60 NS5b 60 inhibit viral replication 60 Shigatoxin producing E. coli 60 glucocerebroside primarily 60 muscarinic receptor agonists 60 Zemiva TM 60 molecular imaging radiopharmaceuticals 60 tumor suppressors cytokines 60 enhance ApoA 60 protein mTOR 60 TLR7 agonist 60 HGS ETR1 mapatumumab 60 siRNA compounds 60 gamma secretase activating 60 TransVax tm 60 mRNA mediated 60 engineered proteases 60 MTP inhibitor 60 oncolytic virus therapies 60 thrombin component 60 Crucell genetically engineered 60 based pretargeting methods 60 proteasome inhibitor 60 cytotoxic antibody 60 TRIOLEX ™ 60 OMP #M# 60 CoVal TM fusion 60 protein kinase inhibitor 60 myelofibrosis polycythemia vera 60 FGFs 60 CYC# 60 Anticalins R 60 MKC# MT 60 oral picoplatin 60 potently inhibited 60 isoform selective 60 certain protein tyrosine 60 CORT # estimates 60 biomarkers predictive 60 GVAX ® 60 ocular formulation 60 Hedgehog inhibitor 60 molecular biomarkers 60 organ transplant rejection 60 CXCR4 receptor 59 ATRA IV 59 hormone gastrin 59 monoclonal antibody MAb 59 diabetic retinopathy hyphema glaucoma 59 CD# CEA 59 antiangiogenesis 59 cisplatin resistant 59 HUMIRA resembles 59 cyclin dependent kinase inhibitor 59 Lenocta TM sodium stibogluconate 59 GlycoPEGylated hemostasis compounds 59 POTELLIGENT ® Technology 59 DNA methyltransferase inhibitors 59 5 HT2A inverse 59 multiple sclerosis psoriasis 59 CYP#A# CYP#D# 59 small molecule glucokinase 59 Epothilones 59 Curaxin 59 protein tyrosine phosphatases 59 candidate REP# 59 selective kinase inhibitor 59 ovarian endometrial 59 Gleevec inhibits 59 small molecule tyrosine 59 CCR2 receptor 59 oncolytic viruses 59 Biosensor System revolutionary 59 ionotropic glutamate receptor antagonists 59 Monoclonal antibody 59 ovarian cancer chronic hepatitis 59 TLR8 59 Speedel develops 59 HepDirect technology 59 IAP inhibitors 59 JAK2 inhibitor 59 NEUGENE 59 receptor inhibitors 59 IL-#/# 59 novel peptide 59 Eg5 kinesin motor 59 novel VDA molecule 59 Pentad TM 59 pathophysiological effects 59 investigational humanized monoclonal antibody 59 JAK#/JAK# 59 druggable targets 59 auristatin E MMAE 59 Tumour Vascular Disrupting Agent 59 dysplastic lesions caused 59 potent antiproliferative 59 Presently DARA 59 BHT DNA 59 biologic therapeutics 59 Topoisomerase II 59 p# inhibitor 59 Locked Nucleic Acid 59 primarily enzymatic reactions 59 next generation URAT1 59 metastatic colorectal 59 drugable targets 59 novel antibody therapeutics 59 sores onychomycosis nail 59 targeted anticancer biopharmaceuticals 59 integrative pharmacology 59 ADMET database 59 #beta HSD 1 59 potent suppressor 59 protein kinase inhibitors 59 BRAF mutant 59 PDE4 modulators 59 diagnostic molecular imaging 59 Panzem 59 lymphomas leukemias 58 PDE# 58 PI3K/Akt pathway inhibitor 58 tubulin inhibitor 58 oncology metabolic disorders 58 immunotherapeutic approaches 58 NF kB Decoy 58 MEK inhibitors 58 B lymphocyte stimulator 58 novel anticancer 58 muscarinic receptor agonist 58 lead molecular radiotherapeutic 58 PDGF alpha receptor 58 agonistic human 58 BRAF kinase 58 detection reagents 58 proprietary polysaccharide 58 oral ghrelin agonist 58 MMAE 58 NEUGENE antisense 58 Aganocide ® 58 immunologic diseases 58 anticancer therapeutics 58 Cobalamin TM mediated 58 Enzastaurin 58 cardio metabolic disease 58 angiostatin 58 preclinically 58 oncogenic signaling 58 Additionally Soligenix 58 iSONEP ™ 58 novel immunotherapeutic 58 siRNA therapeutic 58 Additional BiTE antibodies 58 nilotinib Tasigna ® 58 IgG1 monoclonal antibody 58 Tarvacin Anti Cancer 58 ® bortezomib 58 VitiGam 58 viral protease 58 rotavirus shingles 58 non peptide macromolecular 58 G Protein Coupled 58 potent anticancer 58 either acutely decompensated 58 anti PlGF 58 Met receptor tyrosine 58 Nventa proprietary CoVal 58 XL# inhibits 58 sarcoma melanoma 58 Phylomer ® 58 Sudhir Agrawal D.Phil 58 Akt pathway associated 58 Generx TM 58 vaccines oncolytic virus 58 #T# tumor 58 psoriasis inflammatory bowel 58 HCV polymerase 58 inhibit metastasis 58 novel immunomodulatory 58 concerning CombinatoRx 58 immune modulating 58 targeting CD# 58 liposomal delivery 58 Nektar proprietary 58 dasatinib Sprycel 58 Personalized Immunotherapy 58 dependent cellular cytotoxicity 58 PORxin TM 58 mertansine 58 deCODE ProstateCancer TM 58 ENMD # 58 iSONEP TM 58 proprietary HuCNS SC 58 therapeutic monoclonal antibodies 58 IMiDs ® 58 rxRNA 58 platform HDL Mimetic 58 pancreatic colon 58 personalized dendritic 58 mda 7 58 delay bone metastases 58 tests miRview TM 58 viral polymerase 58 CaR 58 protein secreted 58 inhaled TPI ASM8 58 hemorrhagic fever viruses 58 particularly SANCTURA XR 58 histone deacetylation 58 chemosensitizer 58 mGluR4 mGluR2 mGluR5 58 Wnt signaling pathway 58 uses NEUGENE antisense 58 novel therapeutic antibodies 58 bone marrow lymph nodes 58 molecular abnormalities 58 serine proteases 58 DNAi 58 induced pluripotent 58 tyrosine kinase receptor 58 patented DepoVax TM 58 inhibiting tumor 58 Solazed ™ 58 oral proteasome inhibitor 58 chimeric monoclonal antibody 58 human IgG1 monoclonal 58 SinuNase ™ 58 autoimmune uveitis 58 Therapies SRT 58 inflammatory autoimmune diseases 58 DNA gyrase 58 phosphate S1P 58 fibrin derived 58 induce apoptosis programmed 58 nonviral 58 XmAb TM 57 oral prodrug 57 Fleximer 57 inhibiting enzymes 57 ANGPTL4 57 immunotoxin 57 poly ADP ribose polymerase 57 histone deacetylase inhibitors 57 Tekmira SNALP stable 57 vascular disrupting agents 57 severe degenerative ischemic 57 Kinase Inhibitor 57 reversible inhibitor 57 INxin 57 lipid particles SNALP 57 IMiDs R 57 imatinib Gleevec ® 57 4E BP1 57 endosomal release 57 thymidylate synthase 57 small molecule agonists 57 Septin 9 gene 57 applying Lipid Sciences 57 KRAS mutated 57 HER1 57 Romidepsin 57 anti amnesic 57 immune effector 57 targeted antifolate 57 Cotara ® 57 potentially treat nephropathic 57 XmAb ® 57 Janus kinase 57 deriving embryonic stem 57 NPC 1C 57 investigational therapies 57 autoreactive B 57 Provecta TM 57 cyclic AMP cAMP 57 intravenous iclaprim potent 57 hypereosinophilic syndrome 57 nano particle tumor suppressor 57 NASH Huntington 57 neuropathic pain metabolic diseases 57 inhibitor COX 57 atopic dermatitis neonatal 57 carcinoid syndrome diabetes 57 treat musculoskeletal metabolic 57 TKM PLK1 57 proliferative diseases 57 Exelixis compounds 57 essential thrombocythemia ET 57 Ibis T# TM 57 active AKT inhibitor 57 developing Surfactant Replacement 57 chemically modify 57 treat nephropathic cystinosis 57 SMaRT ™ 57 folate analogue metabolic 57 SCIB1 57 Photodynamic therapy PDT 57 proprietary delipidation technologies 57 AKT inhibitor 57 undergoing hematopoietic stem 57 glutamic acid decarboxylase 57 oral transdermal 57 methylation markers 57 proprietary Isolagen Process 57 inhibit EGFR 57 Dyax phage display 57 RAF kinase 57 delta isoform 57 vi Immtech ability 57 mitotic kinesins 57 detoxify harmful 57 matrix metalloproteases 57 experimentally validated 57 sublingual tablet formulation 57 TÎ ² 4 57 fungal bacterial 57 polymer conjugate technology 57 p# MAP kinase 57 c Raf kinase 57 autoreactive T cells 57 inflammatory PDE 57 nephrology oncology supportive 57 anti secretory 57 induced mucositis 57 Panzem R NCD 57 transduce 57 deCODE AF TM 57 Hypoxia Inducible Factor 57 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 57 proprietary LNA 57 lintuzumab SGN 57 Janus Kinase 57 K ras mutations 57 acid phosphatase PAP 57 PI3 kinase 57 TLR9 agonists 57 lymphoid organs 57 JAK1 57 isoform selective inhibitors 57 Adenoviral 57 LymphoStat B belimumab 57 modified oligonucleotides 57 CTLA4 Ig product 57 penetrating peptides 57 A3 adenosine receptor 57 RNA antagonist 57 Epidermal Growth Factor Receptor 57 RDEA# potent 57 multiple simultaneous immunological 57 inhibits Akt activation 57 FGFR 57 angiogenic responses 57 Histone deacetylase 57 lymphoid tumors 57 metastatic carcinoid 57 pralatrexate injection folate analogue 57 Archexin 57 dihydrofolate reductase DHFR 57 mammaglobin 57 sirtuin modulators 57 shape zeta 57 BioMAP Systems 57 bladder ovarian 57 advanced malignant hepatic 57 cathepsins 57 PORxin TM platforms 57 histone deacetylase HDAC inhibitors 57 inhibiting angiogenesis 57 anti CD3 57 migraine headaches neuropathic pain 57 intracellular signaling pathways 57 XL# XL# 57 clinical trials Archexin 57 NeoLipid R 56 prostate cancer antigen prostatic 56 multiplexed assays 56 KSP inhibitor 56 integrin alpha 4 56 capture immunosuppressive particles 56 DGAT 56 drug conjugate 56 tyrosine kinase inhibitor TKI 56 optical biosensors 56 signal transduction inhibitors 56 short hairpin RNAs 56 NS#/#A protease 56 novel immunotherapies 56 recombinant antibody 56 AN# novel 56 inhibit replication 56 evaluating picoplatin 56 Interferons 56 DepoVax TM 56 OcuGene glaucoma genetic 56 mitogen activated protein kinases 56 proprietary biomaterials 56 blood coagulation disorders 56 ESBA# 56 pancreas esophagus 56 induce pluripotency 56 cardio metabolic diseases 56 oral kinase inhibitor 56 Donating CINOD class 56 potent inducer 56 neuronal nicotinic receptor NNR 56 STK# [002] 56 MassARRAY ® 56 antisense inhibitors 56 tumor vascular disrupting 56 treating neuropathic pain 56 dependent RNA polymerase 56 retinoblastoma Rb 56 Sangamo ZFP technology 56 NS4A 56 chemokine receptor 56 highly selective inhibitor 56 anti CD3 monoclonal 56 CysDisplay R 56 triggers apoptosis 56 pharmacodynamic biomarkers 56 immune stimulatory 56 intracellular protein 56 drug GLPG# 56 brivanib 56 humanised antibody designed 56 selective inhibition 56 Dendritic cells DCs 56 Thoroughly cooking eggs 56 PDX pralatrexate 56 hypoxia activated prodrug 56 include Healive TM 56 molecular chaperone regulator 56 ispinesib SB # 56 commercializing novel biotherapeutics 56 accessories autologous 56 neuropathic pain spasticity 56 Neugene 56 osteoporosis osteoarthritis 56 molecularly targeted 56 MDR Gram negative 56 proteasome inhibitors 56 ALK inhibitor 56 potently silencing specific 56 TKB# 56 RONDEL TM 56 GGTase 56 potent inhibitors 56 therapeutic peptide 56 thymidylate synthase TS 56 iPS derived 56 targeted immunotherapies 56 Reports Preclinical Data 56 non nucleoside inhibitor 56 anti angiogenic drugs 56 proprietary Dicer Substrate Technology 56 multitargeted 56 Epstein Barr Virus EBV 56 oxidative stress inducer 56 Receptors GPCRs 56 synthetic cannabinoid library 56 RKIP 56 Sphingomab TM 56 DNA methyltransferases 56 Vytorin combines 56 drug monomethyl auristatin 56 antiproliferative effects 56 used DNA alkylating 56 progressive metastatic prostate 56 Olig2 56 IL #p# 56 dasatinib Sprycel ® 56 dihydrofolate reductase 56 Boiling kills 56 mediated autoimmune diseases 56 Gleevec resistant 56 PROT biotechnology 56 nitric oxide donating 56 Herceptin monoclonal antibody 56 MTHFD1L 56 bioengineered novel 56 mTOR mammalian target 56 biased ligand 56 HepDirect 56 recurrent metastatic ovarian cancer 56 Litx 56 Tß4 56 castration resistant hormone refractory 56 NU# direct 56 siRNA binds 56 potent cytotoxic 56 Ph + acute lymphoblastic 56 commercializing anti infective 56 Immunotherapeutic 56 HMGCR 56 Vaccine Adjuvant 56 ischemic diseases 56 antisense oligonucleotides 56 EGFR signaling pathway 56 Chimigen TM 56 gastrointestinal stromal 56 inverse agonist 56 HTS assay 56 anti mitotic 56 biomarker identification 56 ERK pathway 56 Cintredekin Besudotox 56 p# deficient 56 romazarit 56 DPX Survivac 56 OXIGON TM 56 Novasome R adjuvant 56 ABL inhibitor completing 56 enzyme inhibitor 56 liver colon rectal 56 IMC #B 56 Combivir Kivexa 56 peptidomimetic 56 MAGE A3 ASCI 56 genomic biomarkers 56 HER2 HER2 56 potential biowarfare pathogens 56 tumor angiogenesis inhibitors 56 OncoVex 56 promising anticancer 56 receptor CXCR4 56 AvalonRx R 56 ovarian prostate 56 Pharmos proprietary 56 Terra Incognita Golden 56 DNA methylation biomarkers 56 musculoskeletal metabolic 56 reverse transcriptase inhibitors 56 cytoprotective 56 inhalation anthrax cutaneous anthrax 56 N chlorinated antimicrobial 56 hypoxia inducible factor 56 SIRT4 56 suppresses tumor 56 immunoregulatory 56 HCV replication 56 splice variant 56 peptibody 56 Endotoxin Activity Assay 55 TMEM#B 55 molecular therapeutics immunotherapies 55 monoclonal antibody mAb 55 dimebon latrepirdine 55 oral dihydropyrimidine dehydrogenase DPD 55 Cytotoxic T 55 cancer immunotherapies 55 Squamous cell 55 ImmunoGen proprietary 55 macrocyclic lactone 55 TXNIP 55 candidate Lovaxin C 55 signal transduction inhibitor 55 Maxy G# 55 alvespimycin 55 vinca alkaloids 55 activate p# 55 small molecule modulators 55 TLR9 agonist 55 PORxin 55 epothilones 55 auristatin 55 small molecule defensin 55 CFTR corrector 55 radiation chemoradiation 55 By SALLY SPAULDING 55 visit www.genenews.com 55 neovascular diseases 55 topically delivered 55 antibody mediated 55 Nanobody 55 novel antifolate 55 gastrointestinal mucositis 55 OvaRex R 55 RONDEL ™ 55 include Altastaph TM 55 B Anflu R 55 TAT2 55 rxRNA compounds 55 modified glutathione analog 55 S1P antibody 55 thyroid hormone receptor 55 Nasdaq MITI biopharmaceutical 55 treat refractory angina 55 interferon lambda 55 Current Lm vaccines 55 siRNA Delivery 55 aldehyde dehydrogenase ALDH2 deficiency 55 superantigens 55 gene silencing mechanism 55 Crofelemer budesonide foam 55 Veronate R 55 clinically validated targets 55 Squalamine 55 virus AAV 55 CDDO Im 55 Tarmogen 55 eTag assays 55 aurora kinase inhibitor 55 phage display 55 tubulin binding 55 cardiac myosin 55 Staphylococcus aureus Immune Globulin 55 PROfusion 55 Tyrosine kinases 55 shRNAs 55 transfect cell 55 KRAS oncogene 55 Tarvacin TM 55 lipid nanoparticles 55 inhibiting telomerase 55 intranasal insulin product 55 commercializing aptamer therapeutics 55 HSP# inhibitor 55 integrase enzyme 55 candidate deforolimus 55 sunitinib Sutent ® 55 Transdrug R 55 PI3 K 55 mutated p# 55 IGF1R 55 receptor tyrosine kinase inhibitor 55 tranquilizers diazepam 55 serine protease 55 peptide antigens 55 immunoadhesins 55 XL# XL# XL# XL# 55 ErbB1 55 Aganocide 55 virally infected cells 55 3 kinase PI3K 55 refractory chronic lymphocytic 55 SIRT1 activators 55 Paraffin Embedded FFPE 55 Trofex 55 R sorafenib tablets 55 Elotuzumab 55 small molecule activators 55 Rosetta Genomics microRNA 55 ImmuneY2 55 Thiarabine 55 Ep CAM 55 novel antiviral therapeutics 55 FUSILEV enhances 55 mutant BRAF 55 oxazolidinone 55 AS# amonafide L malate 55 virulence determinants 55 prostate secretory 55 VitiGam TM 55 Multiple Sclerosis Rheumatoid Arthritis 55 erlotinib Tarceva ® 55 neovasculature 55 Dicer Substrate siRNA DsiRNA 55 Nasdaq HALO biopharmaceutical 55 MIF protein 55 epigenetic therapies 55 ALK inhibitors 55 Dendreon investigational 55 radiation sensitizer 55 #T# L1 55 CYP#A# isoenzyme 55 sorafenib tablets 55 metastatic pancreatic 55 Undesirable alterations 55 small molecule activator 55 proliferative disorders 55 Panzem R 55 viral proteins 55 vaccine GRNVAC1 55 anti angiogenic agent 55 recombinant antibodies 55 telomerase therapeutic 55 XSSE OXGN 55 histone deacetylase inhibitor 55 glycan binding 55 Viprovex R 55 siRNA knockdown 55 adecatumumab MT# 55 oral JAK1 55 AEG# 55 GIPET r 55 lupus multiple sclerosis 55 Y2 receptor 55 virulence genes 55 radiolabeled antibodies 55 Stapled Peptide 55 peripherally acting 55 Anticalins ® 55 c Abl 55 combining voreloxin 55 neuro inflammatory 55 biologic pathways 55 antisense inhibition 55 filter cytokines 55 INS# [001] 55 FluCide 55 adenoviral 55 coupled receptor GPCR 55 FLT3 55 FGFR3 55 investigational hepatitis C 55 rheumatoid arthritis thrombocytopenia 55 indolent follicular non 55 antitumour 55 FGFR1 55 albumin naturally occurring 55 adenosine A2A 55 candidate oral AP# 55 class mGluR5 inhibitor 55 patented DepoVax ™ 55 metaglidasen 55 PKC alpha 55 Fc fusion protein 55 Eg5 55 Flt3 55 evaluating T DM1 55 bacterial enzyme 55 RAF kinase VEGFR 55 modulates Akt 55 acting fibrinolytic 55 genomes metagenomics RNA 55 RXi proprietary 55 divide uncontrollably 55 vitro assay 55 product candidate Lpathomab 55 Monoclonal 55 R Saizen R 55 PTP 1B 55 antibiotics antifungals 55 telomerase inhibitors 55 engineered RAP peptides 55 HepDirect prodrug 55 aurora kinase 55 proprietary PEGylation 55 autoreactive 55 Sapacitabine 55 commercialize deforolimus 55 BCL2 55 AMPK activators 55 BiTE R 55 leukocyte adhesion 55 adenosine receptor 55 rusalatide acetate 55 NF kB pathway 55 FBPase 55 selective kinase inhibitors 55 leukotriene pathway 55 novel peptides 55 p# MAPK 55 histone deacetylase 55 FOLFOX6 chemotherapy regimen 55 kinase inhibition 55 inflammation autoimmune diseases 55 factor TNF receptor 55 destroy cancerous cells 55 RNA antagonists 55 mTOR inhibitors 55 triterpenoids 55 flu mAb 55 abnormal lymphocytes 54 splice variants 54 mRNAs thereby preventing 54 histone deacetylases HDAC 54 AQD class 54 PCA3 gene 54 Mycobacterium tuberculosis MTB 54 inhibit oxidative stress 54 Seliciclib 54 Albuferon albinterferon alfa 2b 54 oral ferric iron 54 Trofex TM 54 chemopreventive agents 54 mechanistic biomarkers 54 XmAb 54 Umbilical cord stem cells 54 specific chemokine receptors 54 selective orally bioavailable 54 Deforolimus 54 Onconase 54 Novavax VLP vaccine 54 Zemiva ™ 54 membrane receptors 54 adrenergic regulation 54 predictive biomarkers 54 TELINTRA R 54 pan HDAC inhibitor 54 agonist compounds 54 CA9 SCAN 54 itraconazole Sporanox 54 intracellular pathways 54 MAbs 54 immuno inflammatory 54 tumor metastases 54 Galectins 54 marrow reprogram 54 Siglec 8 54 mitogen activated ERK kinase 54 activatable 54 immunotherapeutic 54 osteoprotegerin OPG 54 telomerase inhibitor drug 54 epithelial tumors 54 Ii protein 54 humanised monoclonal antibody 54 maturation inhibition 54 cortisol synthesis 54 #beta HSD1 54 HEPLISAV TM hepatitis B 54 CDK inhibitors 54 GPCR targets 54 body AVI antiviral 54 fusion inhibitor 54 MT#/MEDI-# 54 induce apoptosis 54 LRP5 54 sapropterin dihydrochloride Phase 54 diseases osteoarthritis osteoporosis 54 proteosome 54 novel chimeric natriuretic 54 Furthermore PLX 54 Cyclosert TM 54 tuberculosis strep throat 54 oncogenic transformation 54 demonstrated antitumor activity 54 Selective Inhibitor 54 defensins 54 Posiphen TM 54 introduced NEUGENE 54 Fleximer R 54 enabled ARIUS 54 NEAL F. RATTICAN 54 KinomeScan 54 Ribavirin causes 54 intracellular pathogens 54 Viprovex TM 54 cytolytic activity 54 NS5B polymerase 54 immunological diseases 54 Emergent marketed 54 Atripla combines 54 SIX ROG VX 54 Daclizumab 54 molecular imaging radiopharmaceutical 54 TRIM5a 54 include Phenoptin TM